Skip to content

Efficacy of Postoperative Pain Control Between Transarticular VS Periartiucular Multimodal Drug Infiltration in Total Hip Arthroplasty: Double-blinded Randomized Control Trial

Efficacy of Postoperative Pain Control Between Transarticular VS Periartiucular Multimodal Drug Infiltration in Total Hip Arthroplasty: Double-blinded Randomized Control Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05325671
Enrollment
120
Registered
2022-04-13
Start date
2022-04-05
Completion date
2023-10-31
Last updated
2024-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty Complications, Pain, Post Operative

Keywords

total hip arthroplasty, transarticular multimodal drug infiltration, periarticular multimodal drug infiltration

Brief summary

This research aim to improve postoperative outcome in total hip arthroplasty(THA) by using local mixture infiltration as bupivacaine + NSAID + epinephrine + tranxemic acid. In the present time these mixture components has shown to improve THA outcome by aspect of postoperative pain control, postoperative opioid consumption, postoperative bleeding, LOS and postoperative rehabilitation without increasing complication but the accuracy of infiltration technique which gives the best outcome has not been yet discovered.Recently study by Hashimoto et al has risen that these technique can be administrated by both periarticular and intra-articular approach.By considering the complexity of human anatomy around the hip tissue we assume that the intra-articular(transarticular) may given equivalence (may be better) outcome with lowering procedural related complication comparing to periarticular infiltration approach.

Interventions

PROCEDUREtransarticular multimodal drug infiltration

as described previously

Sponsors

Department of Medical Services Ministry of Public Health of Thailand
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* patient who would go on cemented and cementless THA * age 45-60 years of age * voluntary decision

Exclusion criteria

* bilateral THA * revision surgery * history of pelvic and hip surgery previously * allergy to medication in protocol * CKD stage 4-5, chronic liver disease with Child Pugh B or C * pregnancy * history of hip injection * U/D * hypercoagulable state * abnormal laboratory coagulation study as INR \> 1.4 or aPTT \> 1.4 * abnormal platelet function * thrombocytopenia * PE , DVT, ischemic stroke, CAD/ischemic heart disease * use of anticoagulant or hormonal usage * anesthesia by general anesthesia or additional nerve block * can not understand PCA usage * use postopertive wound drainage

Design outcomes

Primary

MeasureTime frame
Visual analogue scale at rest on postoperative day1st and 2nd1 week

Secondary

MeasureTime frame
total morphine consumption in first 24 hours postoperative period via PCA pump1 week
total morphine consumption in whole postoperative period1 week
length of stay1 week
postoperative complication1 week

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026